Project BioShield Procurement
Administers late-stage medical countermeasure development with United States government procurement pathways for strategic stockpile readiness.
Project BioShield, authorized by the Project BioShield Act of 2004 and funded through the Biomedical Advanced Countermeasure Development Fund, is the U.S. government's procurement mechanism for late-stage medical countermeasures (MCMs) against CBRN threats. BARDA administers Project BioShield contracts on behalf of the U.S. Department of Health and Human Services, using the authority to acquire MC…
Late-stage medical countermeasures against CBRN threats: vaccines, antivirals, antitoxins, antimicrobials, radiation/nuclear countermeasures, chemical countermeasures, burn and blast countermeasures.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up